Daily Newsletter

04 September 2023

Daily Newsletter

04 September 2023

Globus Medical merges with spine technology company Nuvasive

The merger is expected to provide a better opportunity for increased revenue.

RanjithKumar Dharma September 04 2023

Musculoskeletal solutions company Globus Medical has concluded the previously announced merger with spine technology company NuVasive.

In February of this year, Globus Medical agreed to acquire Nuvasive in an all-stock transaction valued at approximately $3.1bn.

The merged company will offer an extensive range of musculoskeletal procedural solutions and technologies to surgeons and patients, making a significant impact on the continuum of care.

Globus Medical president and CEO Dan Scavilla said: “We’re thrilled to begin our journey together to create a leading global musculoskeletal company.

“With a relentless focus on changing patient lives, we’re combining our differentiated portfolios and talented teams to reach more customers as we advance spine and orthopaedic care globally.”

The merger of Globus Medical and NuVasive unites their global presence, commercial reach and extensive spine and orthopaedic portfolios.

It will also help improve product development, surgeon training and operational capacity.

Furthermore, the merger is expected to provide a better opportunity for increased revenue and a robust financial foundation to generate value.

Globus Medical has approved its board of directors’ expansion from eight members to 11, in connection with the transaction's completion and following the terms outlined in the merger agreement with NuVasive.

Three members from NuVasive's board, John DeFord, Leslie Norwalk and Daniel Wolterman, have been appointed to the Globus Medical board with immediate effect.

NuVasive's former CEO Chris Barry said: “The combination with Globus Medical is highly transformative - bringing together two leading companies with a shared vision to change the lives of more patients around the globe.”

Medical robotics set to witness robust growth in the next decade

GlobalData expects every segment of the medical robotics market to grow over the next decade, driven by the demands of high-volume procedures. Per GlobalData forecasts, the surgical robotics market is expected to grow at a CAGR of 8% by 2030. Surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robot models will offer new surgical possibilities, such as micro-robots to address difficult-to-treat diseases.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close